2012
DOI: 10.1016/j.trre.2011.10.001
|View full text |Cite
|
Sign up to set email alerts
|

Effects of brain death on organ quality and transplant outcome

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

3
70
0
1

Year Published

2013
2013
2022
2022

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 98 publications
(74 citation statements)
references
References 76 publications
3
70
0
1
Order By: Relevance
“…Both of these circulatory conditions require pharmacological control of blood pressure, either through administra tion of short halflife antihypertensives in hypertension or through sufficient fluid resuscitation and administra tion of catecholamines in hypotension. 8 Colloidal fluids should be used with care as they can harm renal func tion and accumulate in the hepatic reticuloendothelial system. 9,10 In brain death, failure of neurohypophysal function with consequent central diabetes insipidus requires administration of vasopressin.…”
Section: Pretreatment Measuresmentioning
confidence: 99%
“…Both of these circulatory conditions require pharmacological control of blood pressure, either through administra tion of short halflife antihypertensives in hypertension or through sufficient fluid resuscitation and administra tion of catecholamines in hypotension. 8 Colloidal fluids should be used with care as they can harm renal func tion and accumulate in the hepatic reticuloendothelial system. 9,10 In brain death, failure of neurohypophysal function with consequent central diabetes insipidus requires administration of vasopressin.…”
Section: Pretreatment Measuresmentioning
confidence: 99%
“…Consequently, a cascade of inflammatory events is unleashed, leading to exacerbation of ischemia/reperfusion injury and an impaired graft survival. 25 To identify biomarkers for DBD transplant recipients, a study was performed by Welberry Smith et al 9 Their findings revealed that serum aminoacylase-1 (ACY-1) levels at day 1 or 3 post-transplant were significantly associated with delayed, slow, and immediate graft function, particularly dialysis-free survival, by using proteomic analysis of long-term follow-up of 54 renal transplant patients. 9 Furthermore, an independent confirmative cohort study was employed among 194 patients to validate the association between serum ACY-1 level and incidence of DGF.…”
Section: Biomarkers For Nonliving Donor Kidneysmentioning
confidence: 99%
“…While advances in tissue-type matching and immunosuppressive protocols have greatly reduced short-term graft dysfunction after renal transplantation, long-term graft function continues to be problematic, especially in patients receiving deceased donor kidneys [1][2][3]. The kidneys of deceased donors are routinely flushed and stored in cold storage (CS) solutions [4].…”
Section: Introductionmentioning
confidence: 99%